查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710158

2025年大肠癌筛检全球市场报告

Colorectal Cancer Screening Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年结直肠癌筛检市场规模将强劲成长。到 2029 年，这一数字将成长至 210.1 亿美元，复合年增长率为 6.1%。预测期内的增长可归因于向非侵入性筛检方法的转变、家庭筛检测试的增加、肥胖盛行率的上升、基于价值的医疗保健的采用率的提高以及官民合作关係关係的增加。预测期内的关键趋势包括人工智慧在筛检和诊断中的整合、筛检指南向年轻人群的扩展、广泛使用基因组检测来检测癌症风险、行动医疗(行动医疗) 平台的增长以及製药和诊断公司之间的合作。

预计未来几年老龄人口的增加将推动大肠癌筛检市场的成长。老化是指人口结构的一种趋势，其特征是劳动年龄人口中老年人口（一般为 65 岁及以上）的比例不断增加，这通常是由于预期寿命延长和出生率下降造成的。随着预期寿命的增加和出生率的下降，世界人口中老年人的比例不断增加。大肠直肠癌筛检透过早期发现和采取预防措施，在满足日益增长的老年人口的需求方面发挥关键作用。这对于解决老年人日益增加的癌症风险和改善他们的整体健康状况至关重要。例如，根据美国非营利研究机构人口研究委员会（PRB）2024年1月的资料，预计美国65岁及以上人口数量将从2022年的5800万增长到2050年的8200万，增幅为47%。此外，老年人口在总人口中所占比例预计将从17%上升至23%。因此，老龄人口的增加是大肠直肠癌筛检市场的主要驱动力。

大肠直肠癌筛检市场的关键参与企业正专注于开发创新解决方案，例如非侵入性、多靶点粪便核糖核酸 (RNA) 结直肠癌筛检测试，以提供可行且有效的早期检测方法，改善患者预后并鼓励更广泛地参与筛检。非侵入性多标靶粪便RNA结直肠癌筛检检测可透过评估粪便检体中的RNA标记来识别结直肠癌和癌前病变的存在，为早期检测提供非手术方法。例如，2024年5月，美国生命科学公司Geneoscopy Inc.宣布其ColoSense已获得美国食品药物管理局（FDA）的核准。该测试是一种非侵入性的、基于粪便的筛检方法，使用 RNA 生物标记物，对检测大肠直肠癌的敏感性为 93%，对检测晚期腺瘤的敏感性为 45%。该测试的意义在于它的高准确性，特别是对于年轻人而言，并且透过提供一种比传统测试方法更微创的替代方法，有可能提高筛检率。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球大肠直肠癌筛检PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球大肠直肠癌筛检市场：成长率分析
  • 全球大肠直肠癌筛检市场表现：规模与成长，2019-2024
  • 全球大肠癌筛检市场预测：规模与成长，2024-2029 年，2034 年
  • 全球大肠直肠癌筛检总目标市场（TAM）

第六章市场区隔

  • 全球大肠直肠癌筛检市场类型、表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 根据航班
  • 大便潜血试验（FIT）
  • 大便潜血试验（FOBT）
  • 粪便去氧核糖核酸（DNA）检测
  • 大肠镜检查
  • 其他类型
  • 全球大肠直肠癌筛检市场：依年龄层、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 50岁以下
  • 50-64岁
  • 65岁或以上
  • 全球大肠癌筛检市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 临床实验室
  • 诊断影像中心
  • 其他最终用户
  • 全球大肠癌筛检市场，依粪便检验类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 粪便检验
  • 全球大肠直肠癌筛检市场按大便潜血试验(FIT) 类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 高灵敏度FIT
  • 低灵敏度 FIT
  • 全球大肠直肠癌筛检市场按大便潜血试验(FOBT) 类型细分、绩效及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 癒创木脂粪便潜血试验
  • 免疫化学粪便潜血试验
  • 全球大肠直肠癌去氧核糖核酸市场依粪便 DNA 检测类型、绩效及预测细分，2019-2024 年、2024-2029 年、2034 年
  • 多目标粪便DNA检测
  • 单目标粪便DNA检测
  • 全球大肠癌筛检市场，依大肠镜检查类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断性大肠镜检查
  • 治疗性大肠镜检查
  • 全球大肠癌筛检市场及其他细分市场，依类型、实际规模及预测，2019-2024 年、2024-2029 年、2034 年
  • 虚拟大肠镜检查
  • 柔性乙状结肠镜检查
  • 胶囊内视镜检查

第七章 区域和国家分析

  • 全球大肠癌筛检市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球大肠癌筛检市场：按国家/地区、绩效和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 大肠直肠癌筛检市场：竞争格局
  • 大肠直肠癌筛检市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic Inc.
  • bioMerieux SA
  • QuidelOrtho Corporation
  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • Guardant Health Inc.
  • Eiken Chemical Co. Ltd.
  • HemoCue AB
  • Clinical Genomics Inc.
  • Polymedco LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年大肠癌筛检市场：提供新机会的国家
  • 2029年大肠癌筛检市场：细分领域带来新机会
  • 2029年大肠直肠癌筛检市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31737

Colorectal cancer screening refers to testing procedures aimed at detecting early signs of colorectal cancer before symptoms manifest. Early detection through screening can identify precancerous polyps or cancer at a more treatable stage, significantly enhancing patient outcomes. Screening is recommended for adults starting at age 45, or earlier for those at higher risk.

The primary types of colorectal cancer screening include stool-based tests, fecal immunochemical tests (FIT), fecal occult blood tests (FOBT), stool deoxyribonucleic acid (DNA) tests, and colonoscopy, among others. Stool-based colorectal cancer screening involves analyzing a stool sample for indicators of cancer-related substances or abnormalities, such as blood or DNA mutations, to identify potential colorectal cancer. These screenings are categorized by age groups, including individuals under 50, those aged 50-64, and those over 65. The end users of these tests encompass hospitals and clinics, clinical laboratories, diagnostic imaging centers, and other healthcare providers.

The colorectal cancer screening market research report is one of a series of new reports from The Business Research Company that provides colorectal cancer screening market statistics, including colorectal cancer screening industry global market size, regional shares, competitors with a colorectal cancer screening market share, detailed colorectal cancer screening market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer screening industry. This colorectal cancer screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The colorectal cancer screening market size has grown strongly in recent years. It will grow from $15.61 billion in 2024 to $16.6 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to the increasing incidence of colorectal cancer, rising government awareness campaigns, an aging population, growing adoption of colonoscopy, and improved insurance coverage.

The colorectal cancer screening market size is expected to see strong growth in the next few years. It will grow to $21.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to a shift to non-invasive screening methods, increasing home-based screening tests, growing prevalence of obesity, rising adoption of value-based healthcare, and increasing public-private partnerships. Major trends in the forecast period include the integration of AI in screening and diagnostics, expansion of screening guidelines to younger populations, broader use of genomic testing for cancer risk, growth in mobile health (mHealth) platforms, and collaborations between pharmaceutical and diagnostic companies.

The increasing aging population is projected to drive the growth of the colorectal cancer screening market in the coming years. An aging population refers to a demographic trend characterized by a rising proportion of elderly individuals (typically those aged 65 and older) relative to the working-age population, often resulting from longer life expectancies and declining birth rates. As life expectancies increase and birth rates decline, the share of older adults in the global population continues to grow. Colorectal cancer screening plays a crucial role in addressing the needs of this expanding aging population by enabling early detection and preventive measures, which are essential for managing the heightened cancer risk among older adults and improving their overall health outcomes. For example, in January 2024, data from the Population Reference Bureau (PRB), a U.S.-based nonprofit research organization, projected that the number of Americans aged 65 and older would rise from 58 million in 2022 to 82 million by 2050, representing a 47% increase. Additionally, their share of the total population is expected to grow from 17% to 23%. Thus, the increasing aging population is a significant driver of the colorectal cancer screening market.

Key players in the colorectal cancer screening market are focusing on developing innovative solutions, such as non-invasive multi-target stool ribonucleic acid (RNA) colorectal cancer screening tests, to provide accessible and effective early detection methods, thereby improving patient outcomes and promoting wider screening participation. Non-invasive multi-target stool RNA colorectal cancer screening tests evaluate RNA markers from stool samples to identify the presence of colorectal cancer or precancerous lesions, offering a non-surgical approach for early detection. For instance, in May 2024, Geneoscopy Inc., a U.S.-based life sciences company, announced that it received U.S. Food and Drug Administration (FDA) approval for ColoSense. This test utilizes RNA biomarkers for a non-invasive, stool-based screening method that demonstrated 93% sensitivity in detecting colorectal cancer and 45% sensitivity for advanced adenomas. Its significance lies in its high accuracy, particularly among younger populations, and its potential to enhance screening rates by providing a less invasive alternative to traditional methods.

In November 2023, Geneoscopy Inc. partnered with Laboratory Corporation (LabCorp), a U.S.-based life science and healthcare company, to broaden access to Geneoscopy's non-invasive multi-target stool RNA colorectal cancer screening test. This collaboration aims to improve early and sensitive detection of colorectal cancer and precancerous lesions, address health disparities, and increase screening rates by leveraging LabCorp's extensive network of healthcare providers and patients. LabCorp is known for offering colon cancer screening and diagnostic tests.

Major companies operating in the colorectal cancer screening market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, FUJIFILM Holdings Corporation, GE HealthCare, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., bioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., Eiken Chemical Co. Ltd., HemoCue AB, Clinical Genomics Inc., Polymedco LLC, Hemosure Inc., Geneoscopy Inc., Novigenix SA

North America was the largest region in the colorectal cancer screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the colorectal cancer screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The colorectal cancer screening market includes revenues earned by entities by providing services such as genetic and molecular testing, patient education and awareness programs, and screening result analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Colorectal Cancer Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on colorectal cancer screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for colorectal cancer screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The colorectal cancer screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Stool-Based; Fecal Immunochemical Test (FIT); Fecal Occult Blood Test (FOBT); Stool Deoxyribonucleic Acid (DNA) Test; Colonoscopy; Other Types
  • 2) By Age Group: Below 50 Years; 50-64 Years; Above 65 Years
  • 3) By End User: Hospitals And Clinics; Clinical Laboratories; Diagnostic Imaging Centers; Other End-Users
  • Subsegments:
  • 1) By Stool-Based Tests: Stool-Based Tests
  • 2) By Fecal Immunochemical Test (FIT): High-Sensitivity FIT; Low-Sensitivity FIT
  • 3) By Fecal Occult Blood Test (FOBT): Guaiac FOBT; Immunochemical FOBT
  • 4) By Stool Deoxyribonucleic Acid (DNA) Test: Multi-Target Stool DNA Test; Single-Target Stool DNA Test
  • 5) By Colonoscopy: Diagnostic Colonoscopy; Therapeutic Colonoscopy
  • 6) By Other Types: Virtual Colonoscopy; Flexible Sigmoidoscopy; Capsule Endoscopy
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Medtronic plc; Siemens Healthineers
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Colorectal Cancer Screening Market Characteristics

3. Colorectal Cancer Screening Market Trends And Strategies

4. Colorectal Cancer Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Colorectal Cancer Screening Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Colorectal Cancer Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Colorectal Cancer Screening Market Growth Rate Analysis
  • 5.4. Global Colorectal Cancer Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Colorectal Cancer Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Colorectal Cancer Screening Total Addressable Market (TAM)

6. Colorectal Cancer Screening Market Segmentation

  • 6.1. Global Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stool-Based
  • Fecal Immunochemical Test (FIT)
  • Fecal Occult Blood Test (FOBT)
  • Stool Deoxyribonucleic Acid (DNA) Test
  • Colonoscopy
  • Other Types
  • 6.2. Global Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Below 50 Years
  • 50-64 Years
  • Above 65 Years
  • 6.3. Global Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Clinical Laboratories
  • Diagnostic Imaging Centers
  • Other End-Users
  • 6.4. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool-Based Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stool-Based Tests
  • 6.5. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Immunochemical Test (FIT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • High-Sensitivity FIT
  • Low-Sensitivity FIT
  • 6.6. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Fecal Occult Blood Test (FOBT), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Guaiac FOBT
  • Immunochemical FOBT
  • 6.7. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Stool Deoxyribonucleic Acid (DNA) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-Target Stool DNA Test
  • Single-Target Stool DNA Test
  • 6.8. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Colonoscopy
  • Therapeutic Colonoscopy
  • 6.9. Global Colorectal Cancer Screening Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Virtual Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy

7. Colorectal Cancer Screening Market Regional And Country Analysis

  • 7.1. Global Colorectal Cancer Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Colorectal Cancer Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Colorectal Cancer Screening Market

  • 8.1. Asia-Pacific Colorectal Cancer Screening Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Colorectal Cancer Screening Market

  • 9.1. China Colorectal Cancer Screening Market Overview
  • 9.2. China Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Colorectal Cancer Screening Market

  • 10.1. India Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Colorectal Cancer Screening Market

  • 11.1. Japan Colorectal Cancer Screening Market Overview
  • 11.2. Japan Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Colorectal Cancer Screening Market

  • 12.1. Australia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Colorectal Cancer Screening Market

  • 13.1. Indonesia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Colorectal Cancer Screening Market

  • 14.1. South Korea Colorectal Cancer Screening Market Overview
  • 14.2. South Korea Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Colorectal Cancer Screening Market

  • 15.1. Western Europe Colorectal Cancer Screening Market Overview
  • 15.2. Western Europe Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Colorectal Cancer Screening Market

  • 16.1. UK Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Colorectal Cancer Screening Market

  • 17.1. Germany Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Colorectal Cancer Screening Market

  • 18.1. France Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Colorectal Cancer Screening Market

  • 19.1. Italy Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Colorectal Cancer Screening Market

  • 20.1. Spain Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Colorectal Cancer Screening Market

  • 21.1. Eastern Europe Colorectal Cancer Screening Market Overview
  • 21.2. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Colorectal Cancer Screening Market

  • 22.1. Russia Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Colorectal Cancer Screening Market

  • 23.1. North America Colorectal Cancer Screening Market Overview
  • 23.2. North America Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Colorectal Cancer Screening Market

  • 24.1. USA Colorectal Cancer Screening Market Overview
  • 24.2. USA Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Colorectal Cancer Screening Market

  • 25.1. Canada Colorectal Cancer Screening Market Overview
  • 25.2. Canada Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Colorectal Cancer Screening Market

  • 26.1. South America Colorectal Cancer Screening Market Overview
  • 26.2. South America Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Colorectal Cancer Screening Market

  • 27.1. Brazil Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Colorectal Cancer Screening Market

  • 28.1. Middle East Colorectal Cancer Screening Market Overview
  • 28.2. Middle East Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Colorectal Cancer Screening Market

  • 29.1. Africa Colorectal Cancer Screening Market Overview
  • 29.2. Africa Colorectal Cancer Screening Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Colorectal Cancer Screening Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Colorectal Cancer Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Colorectal Cancer Screening Market Competitive Landscape And Company Profiles

  • 30.1. Colorectal Cancer Screening Market Competitive Landscape
  • 30.2. Colorectal Cancer Screening Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Colorectal Cancer Screening Market Other Major And Innovative Companies

  • 31.1. FUJIFILM Holdings Corporation
  • 31.2. GE HealthCare
  • 31.3. Boston Scientific Corporation
  • 31.4. Olympus Corporation
  • 31.5. Hologic Inc.
  • 31.6. bioMerieux SA
  • 31.7. QuidelOrtho Corporation
  • 31.8. Sysmex Corporation
  • 31.9. QIAGEN N.V.
  • 31.10. Exact Sciences Corporation
  • 31.11. Guardant Health Inc.
  • 31.12. Eiken Chemical Co. Ltd.
  • 31.13. HemoCue AB
  • 31.14. Clinical Genomics Inc.
  • 31.15. Polymedco LLC

32. Global Colorectal Cancer Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Colorectal Cancer Screening Market

34. Recent Developments In The Colorectal Cancer Screening Market

35. Colorectal Cancer Screening Market High Potential Countries, Segments and Strategies

  • 35.1 Colorectal Cancer Screening Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Colorectal Cancer Screening Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Colorectal Cancer Screening Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer